Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for reducing vasopressor use in ICU patients with septic shock
IRCT20151108024938N4Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of midodrine in septic shock (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: ICU length of stay, Duration of intravenous vasopressor therapy and 3 more. Started Oct 2025; status: completed.
02
Drugs
midodrine
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20151108024938N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151108024938N4.